Q3 2020 Sales Performance

Deliver an industry leading margin 15.5% 17.7% 19.8% gsk 20.8% • Power brand mix • Cost & cash discipline • Strategic resource allocation • Supply chain efficiency + • £0.5bn synergies New guidance for new JV Mid to high 20s% by 2022 1 Guidance for existing GSK Consumer Healthcare Approaching mid 20s% by 20221 • Up to 25% reinvested 11.3% FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 1At 2017 constant exchange rates. Expected 20%+ operating margin by 2020 at 2015 constant exchange rates. Historical margins shown for the GSK Consumer Healthcare segment are at respective actual rates 2022 76

View entire presentation